Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy

Autonomic Neuroscience: Basic and Clinical

Volumn 119, Issue 1, 2005, Pages 56-60

  Matsui, Hideaki ^a   Udaka, Fukashi ^a   Oda, Masaya ^a   Kubori, Tamotsu ^a   Nishinaka, Kazuto ^a   Kameyama, Masakuni ^a  

^a SUMITOMO HOSPITAL   (Japan)

Author keywords

123Iodine labelled metaiodobenzylguanidine (MIBG); Autonomic nervous system; Multiple system atrophy; Parkinson's disease

Indexed keywords

(3 IODOBENZYL)GUANIDINE;

ADRENERGIC SYSTEM; AGED; ARTICLE; ATROPHY; CONTROLLED STUDY; FEMALE; HEART; HUMAN; IMAGING; LUNG PARENCHYMA; MALE; NERVE CONDUCTION; PARKINSON DISEASE; PATIENT; PRIORITY JOURNAL; SCINTIGRAPHY; SHOULDER; THYROID GLAND;

3-IODOBENZYLGUANIDINE; AGED; FEMALE; HUMANS; LIVER; LUNG; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; RADIONUCLIDE IMAGING; THYROID GLAND;

EID: 18944380995     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2005.03.003     Document Type: Article

References (23)

1. C.C. Chiueh, Z. Zukowska-Grojec, K.L. Kirk, and I.J. Kopin 6-Fluorocatecholamines as false adrenergic neurotransmitters J. Pharmacol. Exp. Ther. 225 1983 529 533
2. M.W. Dae, T. De Marco, E.H. Botvinick, J.W. O'Connell, R.S. Hattner, J.P. Huberty, and M.S. Yuen-Green Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts-implications for clinical studies J. Nucl. Med. 33 1992 1444 1450
3. A. Druschky, M.J. Hilz, G. Platsch, M. Radespiel-Troger, K. Druschky, T. Kuwert, and B. Neundorfer Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT J. Neurol. Sci. 175 2000 3 12
4. D. Fagret, J.E. Wolf, G. Vanzetto, and E. Borrel Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis J. Nucl. Med. 34 1993 57 60
5. S. Gilman, P.A. Low, N. Quinn, A. Albanese, Y. Ben-Shlomo, C.J. Fowler, H. Kaufmann, T. Klockgether, A.E. Lang, P.L. Lantos, I. Litvan, C.J. Mathias, E. Oliver, D. Robertson, I. Schatz, and G.K. Wenning Consensus statement on the diagnosis of multiple system atrophy J. Neurol. Sci. 163 1999 94 98
6. J.V. Glowniak, F.E. Turner, L.L. Gray, R.T. Palac, S.M. Lagunas, and W.R. Woodward Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants J. Nucl. Med. 30 1989 1182 1191
7. 18F]fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function-studies in normal humans Clinic. Auton. Res. 7 1997 17 29
8. D.S. Goldstein, C.S. Holmes, R. Dendi, S.R. Bruce, and S.T. Li Orthostatic hypotension from sympathetic denervation in Parkinson's disease Neurology 58 2002 1247 1255
9. 123I]iodobenzylguanidine in neurological patients with autonomic failure J. Auton. Nerv. Syst. 49 1994 81 84
10. 123I-metaiodobenzylguanidine Neurol. Med. 47 1997 158 163
11. 123I]iodobenzylguanidine in neurological patients with autonomic failure J. Auton. Nerv. Syst. 53 1995 230 234
12. M.M. Hoehn, and M.D. Yahr Parkinsonism: onset, progression and mortality Neurology 17 1967 427 442
13. A.J. Hughes, S.E. Daniel, L. Kilford, and A.J. Lees Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J. Neurol. Neurosurg. Psychiatry 55 1992 181 184
14. W.A.D.H. Jager, and J. Bethlem The distribution of Lewy bodies in the central and autonomic nervous system in idiopathic paralysis agitans J. Neurol. Neurosurg. Psychiatry 23 1960 283 290
15. J.W. Langston, and L.S. Forno The hypothalamus in Parkinson's disease Ann. Neurol. 3 1978 129 133
16. M.R. Matthews Autonomic ganglia in multiple system atrophy and pure autonomic failure R. Bannister C.J. Mathias Autonomic Failure 3rd ed. 1992 Oxford University Press Oxford 593 621
17. M. Nakajo, K. Shimabukuro, H. Yoshimura, R. Yonekura, Y. Nakabeppu, P. Tanoue, and S. Shinohara Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart J. Nucl. Med. 27 1986 84 89
18. A.H. Rajput, and B. Rozdilsky Dysautonomia in parkinsonism. A clinicopathological study J. Neurol. Neurosurg. Psychiatry 39 1976 1092 1100
19. M.J. Reinhardt, F.D. Jungling, T.M. Krause, and S. Braune Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake Eur. J. Nucl. Med. 27 2000 595 600
20. J.C. Sisson, B. Shapiro, L. Meyers, S. Mallette, T.J. Mangner, D.M. Wieland, J.V. Glowniak, P. Sherman, and W.H. Beierwaltes Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man J. Nucl. Med. 28 1987 1625 1636
21. J.C. Sisson, G. Bolgos, and J. Johnson Measuring acute changes in adrenergic nerve activity oh the heart in the living animal Am. Heart J. 121 1991 1119 1123
22. 123I-BMIPP single photon emission computed tomography Jpn. J. Diag. Imag. 22 2002 749 759
23. J. Taki, K. Nakajima, E.H. Hwang, I. Matsunari, K. Komai, M. Yoshita, K. Sakajiri, and N. Tonami Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific Eur. J. Nucl. Med. 27 2000 566 573